Business information requirements for the performance management of aseptic dispensing in the national health service

The purpose of this research is to determine the information to be collected for aseptic dispensing in NHS hospitals, and its use for management and business purposes in relation to capacity, demand, performance and efficiency. Mixed methodologies were adopted on an exploratory basis. Qualitative methods included: regular expert input; workshops; out-turn questionnaires; Affinity Analysis; surveys; and structured interviews. Quantitative methods included: activity data surveys; targeted surveys; and Delphi methods. The research systematised the collection and collation of the required data and determined novel ways of analysing and manipulating it to aid decision-making. These were used to evaluate the impact of major capital investment and variations in practices between different parts of the country. A benchmarking approach should be applied in utilising the data and statistical indicators. Nomenclature issues can influence data quality. Therefore clear, unambiguous guidance was developed for data collection. Existing pharmaceutical information systems will be the main sources of the data for the foreseeable future. The research focused on the North West of England, with successful application in the West Midlands. Its transferability to non-NHS and foreign hospitals is inferred, as long as similar operational arrangements apply. The research enables: the measurement of progress towards implementing the Breckenridge (1996) recommendations; the evaluation of performance for aseptic production and usage to inform capacity planning; and the presentation of the degree of collaboration between hospitals. The research addresses the absence of set data for an important hospital support service, and applies relevant lessons from other fields and industries. It enables a systematic approach to capacity planning and performance evaluation, at a time when the contribution of the service to support clinical governance is being fully recognised.

Name dc:type.qualificationname

phd

Level dc:type.qualificationlevel

doctoral

Grantor dc:publisher.institution

Liverpool John Moores University

Year dc:date.issued

2007

Author dc:creator

• Gandy, R J

• HF5001 Business
• QR355 Virology
• RS Pharmacy and materia medica

DOI dc:identifier.doi

https://doi.org/10.24377/LJMU.t.00005826

OAI identifier oai:identifier

oai:researchonline.ljmu.ac.uk:5826